Metagenomi, Inc Common Stock

Quarterly Financials

Values in thousands 2024-09-30 2024-06-30 2024-03-31 2023-12-31
Revenue
$11,514
$20,008
$11,159
$12,399
Gross Profit
11,514
18,699
9,886
11,198
EBITDA
-21,019
-15,554
-27,759
-15,367
EBIT
-22,383
-16,863
-29,032
-16,568
Net Income
-18,773
-10,739
-25,148
-19,294
Net Change In Cash
11,514
20,008
11,159
12,399
Free Cash Flow
-27,838
-26,974
-30,765
-22,329
Cash
25,117
61,181
102,558
140,603
Basic Shares
36,766
36,625
21,137
37,472

Annual Financials

Values in thousands 2023-09-30 2022-09-30 2021-09-30
Revenue
$44,756
$17,200
$243
Gross Profit
-49,647
15,467
-144
EBITDA
-56,021
-39,193
-20,753
EBIT
-60,228
-40,926
-21,140
Net Income
-68,255
-43,593
-21,442
Net Change In Cash
44,756
17,200
243
Free Cash Flow
-101,223
15,747
21,354
Cash
140,603
184,441
39,296
Basic Shares
37,527
29,964
29,964

Earnings Calls

Quarter EPS
2024-09-30
-$0.51
2024-06-30
-$0.29
2024-03-31
-$1.19
2023-12-31
-$0.51